New York, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The global increase in the demand for organs for transplant can be attributed to increasing incidences of acute diseases, which in turn results in an increase in the number of organ failures. The growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to the growth of the market.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/transplantation-market/request-sample
Technological Advancements in Organ Transplant Methods to Drive the Transplantation Market
Advanced technologies have led to an evolution in organ transplantation techniques and procedures, which is expected to propel market growth. Novel and improved transplantation products, including tissue products, tissue typing technology, and surgical medical instruments can be attributed to market expansion. Technological advancements in the field of 3D bioprinting are also boosting the adoption of organ transplantation.
The continuous shortage of organ donors and the increasing number of patients on the waiting list for organ transplants have increased the demand for 3D bioprinting. These techniques are used to create customized prosthetics, fabricate tissue, and to support transplantation through synthetic models. Therefore, the introduction of such advanced techniques has led to the growth of the transplantation market, driving the number of organ transplant procedures globally.
Regional Analysis
North America and Asia-Pacific are the two important regions of the transplantation market. The North American transplantation market was valued at USD 5,246.3 million in 2021 and is expected to grow at a CAGR of 8.2% during the forecast period, to reach an expected value of USD 10,707.8 million in 2030. In North America, the US dominates the market owing to a large patient pool, favourable reimbursement policies, and an increase in the number of organ transplantation procedures.
The Asia-Pacific transplantation market was valued at USD 2,661.9 million in 2021 and is expected to grow at a CAGR of 11.25% during the forecast period, to reach an expected value of USD 6,485.1 million in 2030. Asia-Pacific comprises growing economies such as Japan, China, and India. These countries have a sizable massive population and a high prevalence of chronic diseases.
Report Scope
| Report Metric | Details |
| Market Size | 29.7 billion by 2030 |
| CAGR | 9.55% (2022-2030) |
| Historical Data | 2019-2020 |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Forecast Units | Value (USD Billion ) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, Applications, End-Users |
| Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
| Key Companies Profiled/Vendors | AbbVie, Inc., Arthrex Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, 21st Century Medicine, BioLife Solutions Inc, Teva Pharmaceuticals, Veloxis Pharmaceuticals |
| Key Market Opportunities | Artificial Organs and Immunosuppressive Drugs to Create New Opportunities for the Transplantation Market |
| Key Market Drivers | Inflating Incidences of Organ Failure Development of Tissue Banks Technological Advancements in Organ Transplant Methods |
Buy Now Full Report @ https://straitsresearch.com/buy-now/transplantation-market
Impact of COVID-19
The fast spread of coronavirus has plunged the global healthcare industry into disarray. Since a significant proportion of coronavirus patients were hospitalized in medical centers, governing bodies were obliged to reschedule optional and non-urgent operations in hospitals and ambulatory care centers. The pandemic also caused a drop in organ transplant surgery enrolment worldwide.
The decrease in the number of transplantation and organ donation procedures is mainly because of factors such as unavailability of resources, engaged surgeons, lockdown, and travel restrictions. Patients with positive reports for COVID-19 were refrained from donating organs due to the possibility of infection. Furthermore, another major concern influencing transplantation operations was the possibility of immunosuppressant drug interactions with COVID-19 therapy agents, which had led to a significant number of organ failures from graft donors.
Market Recovery Timeline
Markets have experienced massive losses as a result of the pandemic, plunging the world into a financial crisis. The COVID-19 pandemic has resulted in significant changes, and the pandemic's long-term effect is concerning. According to the World Economic Forum, recovering from the COVID-19 problem could take up to three years. Nonetheless, the transplantation business is expected to gain traction following a major decline in coronavirus disease caseloads.
Key Highlights
- Based on product, the transplantation market is segmented into immunosuppressive drugs, tissue products, and preservation solutions. The tissue products market was valued at USD 7,528.3 million in 2021 and is expected to grow at a CAGR of 9.2% from 2022 to 2030 to reach an estimated value of USD 16,691.2 million by 2030. The tissue products segment held the highest revenue in 2021.
- Based on application, the transplantation market is segmented into tissue and organ transplantation. The tissue transplantation market was valued at USD 7,907.3 million in 2021 and is expected to grow at a CAGR of 9.7% to reach an estimated value of USD 18,267.0 million by 2030.
- Based on end-user, the transplantation market is segmented into hospitals, transplant centers, and others. The hospital segment was valued at USD 6,481.3 million in 2021 and is expected to grow at a CAGR of 9.1% to reach an estimated value of USD 14,251.9 million by 2030. The hospital segment held the highest market share due to increasing admissions of patients with organ failure.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/transplantation-market/request-sample
List of Key Players
- AbbVie, Inc.
- Arthrex, Inc.
- Zimmer Biomet
- Medtronic
- Novartis AG
- Stryker
- 21st Century Medicine
- BioLife Solutions, Inc
- Teva Pharmaceuticals
- Veloxis Pharmaceuticals
Global Transplantation Market: Segmentation
By Product Type
- Immunosuppressive Drugs
- Tissue Products
- Preservation Solutions
By Application
- Organ Transplantation
- Tissue Transplantation
By End-Users
- Hospitals
- Transplant Centers
- Others
By Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- MEA
TABLE OF CONTENT
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Executive Summary
4 Market Overview
4.1 Report Segmentation & Scope
4.2 Value Chain Analysis: Transplantation Market
4.2.1 Vendor Matrix
4.3 Key Market Trends
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Environment & Regulatory Landscape
4.6 Forecast Factors & Relevance of Impact
4.7 Macro-Economic & Geopolitical Scenario
4.8 Parent Market Overview
4.9 Technology Landscape
4.10 Market Share Analysis
4.11 Potential Venture Analysis
4.12 Regional Price Trends
4.13 Raw Material Trends
4.14 Cost Structure Analysis
4.14.1 Labor Cost
4.14.2 Consumables
4.14.3 Maintenance Cost
4.15 Covid-19 Impact Analysis:
4.15.1 Pre and Post Covid-19 Market Scenario Analysis
4.15.2 Market Recovery Timeline and Challenge
4.15.3 Measures Taken by Top Players
4.15.4 Quarterly Market Revenue and Growth Forecast till 2021
4.15.4.1 North America
4.15.4.2 Europe
4.15.4.3 Asia-Pacific
4.15.4.4 Central and South America and the Caribbean
4.15.4.5 The Middle East and Africa
5 Product Type Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value & Volume)
5.2 Immunosuppressive drugs
5.2.1 Market Size & Forecast (Value & Volume)
5.3 Tissue products
5.3.1 Market Size & Forecast (Value & Volume)
5.4 Preservation solutions
5.4.1 Market Size & Forecast (Value & Volume)
6 Application Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value & Volume)
6.2 Organ transplantation
6.2.1 Market Size & Forecast (Value & Volume)
6.3 Tissue transplantation
6.3.1 Market Size & Forecast (Value & Volume)
7 End User Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value & Volume)
7.2 Hospitals
7.2.1 Market Size & Forecast (Value & Volume)
7.3 Transplant Centers
7.3.1 Market Size & Forecast (Value & Volume)
7.4 Others
7.4.1 Market Size & Forecast (Value & Volume)
8 Regional Overview
8.1 Introduction
8.1.1 Market Size & Forecast (Value & Volume)
8.2 North America
8.2.1 Economic Overview
8.2.2 Market Scenario
8.2.3 U.S.
8.2.4 Canada
8.2.5 Mexico
8.3 Central and South America and the Caribbean
8.3.1 Economic Overview
8.3.2 Market Scenario
8.3.3 Brazil
8.3.4 Argentina
8.3.5 Colombia
8.3.6 Rest of Central and South America and the Caribbean
8.4 Europe
8.4.1 Economic Overview
8.4.2 Market Scenario
8.4.3 Germany
8.4.4 France
8.4.5 The U.K.
8.4.6 Italy
8.4.7 The Rest Of Europe
8.5 Asia-Pacific (APAC)
8.5.1 Economic Overview
8.5.2 Market Scenario
8.5.3 China
8.5.4 Japan
8.5.5 India
8.5.6 Australia
8.5.7 South Korea
8.5.8 Rest Of APAC
8.6 Middle East
8.6.1 Economic Overview
8.6.2 Market Scenario
8.6.3 South Arabia
8.6.4 The UAE
8.6.5 Qatar
8.6.6 Oman
8.6.7 Turkey
8.6.8 The Rest Of Middle East
8.7 Africa
8.7.1 Economic Overview
8.7.2 Market Scenario
8.7.3 Nigeria
8.7.4 South Africa
8.7.5 The Rest Of Africa
9 Competitive Landscape — Manufacturers & Suppliers
9.1 Competition Dashboard
9.2 Industry Structure
9.3 AbbVie, Inc.
9.3.1 Business Overview
9.3.2 Financial Performance
9.3.3 Recent Developments
9.3.4 Portfolio
9.4 Arthrex, Inc.
9.5 Zimmer Biomet
9.6 Medtronic
9.7 Novartis AG
9.8 Stryker
9.9 21st Century Medicine
9.10 BioLife Solutions, Inc
9.11 Teva Pharmaceuticals
9.12 Veloxis Pharmaceuticals
10 Conclusion & Recommendation
11 Acronyms & Abbreviations
Table of Content and Figure @ https://straitsresearch.com/report/transplantation-market/toc
Market News
- In May 2020, AbbVie, Inc. completed the acquisition of Allergan plc. This transaction expanded and diversified the company’s market share and portfolio in different therapeutic areas: Hematologic Oncology, Neuroscience, & Allergan Aesthetics.
News Media
Transplantation Market to Expand at a Healthy CAGR During Forecast Period
Have a Look at the Related Research Report
Transplant Diagnostics Market: Information by Technology (Molecular Assay), Component, Transplant (Solid Organ Transplantation), Application, End-Use, and Region — Forecast till 2029
Renal Replacement Therapy Market: Information by Product (Consumables, Systems), Modalities (Slow Continuous Ultra Filtration), and Region — Forecast till 2029
Smart Orthopedic Implants Market: Information by Application (Knee, Hip), Components (Electronic Components), Implants Procedures (Total Replacement), and Region — Forecast till 2030
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter
